• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Terns Pharmaceuticals Inc (NQ: TERN )

    8.100 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 614
    Open 8.100
    Bid (Size) 7.910 (1)
    Ask (Size) 8.110 (1)
    Prev. Close 8.100
    Today's Range 8.100 - 8.100
    52wk Range 3.260 - 11.40
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
    Terns has a modest market cap of less than $800 million, and its possible upside could be massive. 
    Via The Motley Fool
    Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga

    Performance

    YTD
    +25.00%
    +25.00%
    1 Month
    +12.03%
    +12.03%
    3 Month
    +20.54%
    +20.54%
    6 Month
    +21.99%
    +21.99%
    1 Year
    +64.63%
    +64.63%

    More News

    Read More
    Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
    Via The Motley Fool
    Should You Invest in This Under-the-Radar Weight Loss Stock?
    Via The Motley Fool
    1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More
    Via The Motley Fool
    Top 2 Health Care Stocks That May Collapse This Quarter
    Via Benzinga
    Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Announces Pricing of Upsized $150.15 Million Public Offering
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Terns Announces Proposed Public Offering
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Terns Pharmaceuticals' Oral GLP-1 Reaches Phase 1 Finish Line With Encouraging Weight Loss Data After One Month
    Via Benzinga
    Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
    Via Investor's Business Daily
    TERN Stock Earnings: Terns Pharma Beats EPS for Q2 2024
    Via InvestorPlace
    Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    3 Biotech Stocks That Could Have Investors Grinning Soon
    Via InvestorPlace
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?
    Via The Motley Fool
    EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
    Via Benzinga
    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.